Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eero Ikkala is active.

Publication


Featured researches published by Eero Ikkala.


British Journal of Haematology | 1993

Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications

Eeva Juvonen; Eero Ikkala; Kalevi Oksanen; Tapani Ruutu

Megakaryocyte and erythroid colony formation in vitro by progenitors from the bone marrow and/or blood was studied in 61 patients with essential thrombocythaemia (ET) and 22 patients with reactive thrombocytosis (RT) using the methyl cellulose assay. 47 (77%) of the patients with ET showed megakaryocyte and/or erythroid spontaneous colony formation while 14 (23%) patients did not have any kind of spontaneous colonies. Spontaneous megakaryocyte colony formation was seen in 42 (69%) of the patients and 36 (59%) ET patients showed spontaneous erythroid growth. 31 patients had both types of spontaneous colonies. 11 patients showed only spontaneous megakaryocyte colony formation, and five patients only spontaneous erythroid growth. None of the patients with RT or of the normal controls showed either type of spontaneous growth. Neither the presence of spontaneous megakaryocyte colony formation nor the number of spontaneous colonies correlated with the platelet count. Patients with spontaneous megakaryocyte growth had significantly more often thromboembolic or haemorrhagic problems than those without spontaneous colony formation. In conclusion, it was found that a great majority of patients with ET but none of those with RT grow spontaneous megakaryocyte and/or erythroid colonies. Spontaneous colony formation is strong evidence for a myeloproliferative disorder. The presence of spontaneous colony growth is associated with an increased risk of thromboembolic or haemorrhagic complications regardless of the platelet count, particularly among young patients.


Acta Haematologica | 1975

The Cytochemical β-Glucuronidase Reaction in the Differential Diagnosis of Acute Leukaemias

C. Wasastjerna; E. Vuorinen; Marja Lehtinen; Eero Ikkala; E. Huhtala

The value of the cytochemical beta-glucuronidase (beta-gluc.) reaction in the differential diagnosis of acute leukaemia was assessed in a series of 100 adult patients. A purely granular type of reaction was observed in 7 out of 8 cases of lymphoblastic leukaemia and in 2 of 11 cases of acute leukaemia of uncertain type. Such an exclusively granular reaction was never seen in other types of acute leukaemia. In most cases of myeloblastic, promyelocytic, myelomonocytic and monocytic leukaemia, a positive staining reaction was noted which was either diffuse or a combination of diffuse and finely granular. The cells of one patient with lymphoblastic leukaemia were negative for beta-gluc. A coarsely granular PAS reaction was noted in 5 cases of lymphoblastic leukaemia including the one with negative beta-glu, reaction. Our results show that the beta-gluc, reaction is of definite value in the diagnosis of lymphoblastic leukaemia, and that it is probably more sensitive than the PAS reaction. In monocytic or myelomonocytic leukaemia, the pattern and intensity of staining did not differ appreciably from that seen in myeloblastic leukemia.


Acta Haematologica | 1982

Spontaneous remission in acute myeloid leukaemia.

Tapani Ruutu; L. Teerenhovi; E. Vuorinen; Eero Ikkala; P. Vuopio

Spontaneous complete remission of 2 months’ duration was observed in a 34-year-old man with acute myeloid (monocytic) leukaemia. In vitro culture of granulocyte-monocyte colony-forming units showed no


Blood | 1991

Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin

Eeva Juvonen; Eero Ikkala; Frej Fyhrquist; Tapani Ruutu


British Journal of Haematology | 1990

Haemophiliacs with factor VIII inhibitors in Finland : prevalence, incidence and outcome

V. Rasi; Eero Ikkala


Scandinavian Journal of Haematology | 2009

Transfusion Therapy in Factor XIII (F. S. F.) Deficiency

Eero Ikkala; Gunnar Myllylä; H. R. Nevanlinna


Scandinavian Journal of Haematology | 2009

Platelet function in preleukaemia.

R. Lintula; V. Rasi; Eero Ikkala; Georg Borgström; Pekka Vuopio


Scandinavian Journal of Haematology | 2009

Polycythaemia Vera and Myelofibrosis

Eero Ikkala; J. Rapola; M. Kotilainen


Acta Haematologica | 1963

Papilloedema due to Iron Deficiency Anaemia

Eero Ikkala; Lauri A. Laitinen


Scandinavian Journal of Haematology | 2009

Hereditary thrombocytopenia. Report of three families.

Gunnar Myllylä; Pelkonen R; Eero Ikkala; Apajalahti J

Collaboration


Dive into the Eero Ikkala's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lauri A. Laitinen

Helsinki University Central Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tadeusz Struzik

New York Academy of Medicine

View shared research outputs
Top Co-Authors

Avatar

Eeva Juvonen

Helsinki University Central Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Siurala

University of Helsinki

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge